13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 67 holding rows worth $524,678,504.
- Accession
- 0001791827-25-000005
- Filer
- CIK 1791827
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 67 entries on the cover page, a total value of $524,678,504 stated on the cover page (in dollars after the unit check, H1), rows summing to $524,678,504 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 101137107 | COM | 336,000 | $33,895,680 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,720,902 | $31,217,162 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 50,500 | $26,449,375 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 980,942 | $24,023,270 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 81,000 | $21,432,600 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 80,000 | $21,168,000 | dollars as filed | call |
| NATERA INC COM | 632307104 | Stock | 119,200 | $16,856,072 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 25,400 | $16,109,442 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 353,000 | $15,281,370 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 709,517 | $13,856,867 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 134,000 | $13,188,280 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 180,000 | $12,292,200 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 322,100 | $11,663,241 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 925,000 | $11,363,625 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 39,300 | $10,928,937 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 80,000 | $9,932,000 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 72,000 | $9,684,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 85,700 | $9,478,420 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 44,500 | $9,122,500 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 77,000 | $8,980,510 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 433,100 | $8,480,098 | dollars as filed | call |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 107,000 | $8,163,030 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 535,000 | $7,966,150 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 15,500 | $7,712,800 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 229,000 | $7,682,950 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 94,000 | $7,623,400 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 529,000 | $7,607,020 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 213,000 | $7,531,680 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 481,000 | $7,392,970 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 453,000 | $7,343,130 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 445,000 | $7,289,100 | dollars as filed | |
| DOXIMITY INC CL A | 26622P107 | Stock | 122,500 | $7,108,675 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 258,000 | $6,966,000 | dollars as filed | |
| HEALTHEQUITY INC COM | 42226A107 | Stock | 78,000 | $6,892,860 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 68,500 | $6,062,935 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 750,000 | $5,265,000 | dollars as filed | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 16,800 | $5,178,936 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 800,000 | $5,016,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 400,000 | $4,912,000 | dollars as filed | call |
| IMMUNIC INC | 4525EP101 | COM | 4,454,408 | $4,855,305 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 115,000 | $4,800,100 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 2,197,270 | $4,680,185 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,477,200 | $4,576,046 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 352,124 | $3,612,792 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 336,200 | $3,563,720 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 145,000 | $3,485,800 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 413,162 | $2,900,397 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 169,000 | $2,807,090 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 87,000 | $2,708,310 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 75,000 | $2,592,750 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 502,600 | $2,452,688 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 57,000 | $2,307,360 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 32,000 | $2,286,400 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 239,000 | $2,268,110 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 645,000 | $2,238,150 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 91,000 | $2,185,820 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 260,000 | $1,859,000 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 60,000 | $1,810,200 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 40,000 | $1,802,000 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 68,000 | $1,391,960 | dollars as filed | |
| AGILON HEALTH INC | 00857U107 | COM | 305,100 | $1,321,083 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 1,228,910 | $1,170,045 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 23,000 | $868,480 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 134,566 | $503,277 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 11,300 | $222,384 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 222,174 | $159,143 | dollars as filed | |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 138,000 | $131,624 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-25-000005 | this filing | 2025-05-15 | acceptance time not in the bulk data set |